Huakang Biomedical Holdings Company Limited Stock
Equities
8622
KYG4644W1069
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.098 HKD | 0.00% | -2.97% | -8.41% |
Sales 2021 | 26.13M 3.61M 28.19M 4.94M | Sales 2022 | 25.33M 3.5M 27.33M 4.79M | Capitalization | 67.72M 9.35M 73.07M 12.8M |
---|---|---|---|---|---|
Net income 2021 | -4M -552K -4.32M -756K | Net income 2022 | -3M -414K -3.24M -567K | EV / Sales 2021 | 1.78 x |
Net cash position 2021 | 34.42M 4.75M 37.14M 6.51M | Net cash position 2022 | 31.43M 4.34M 33.91M 5.94M | EV / Sales 2022 | 1.43 x |
P/E ratio 2021 |
-19.2
x | P/E ratio 2022 |
-21.5
x | Employees | 96 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 56.96% |
1 week | -2.97% | ||
1 month | -16.95% | ||
3 months | -22.22% | ||
6 months | -16.24% | ||
Current year | -8.41% |
Managers | Title | Age | Since |
---|---|---|---|
Chun Guang Zhang
CEO | Chief Executive Officer | 56 | 17-08-02 |
Lai Yin Poon
DFI | Director of Finance/CFO | 52 | 17-08-02 |
Jia Ming He
BRD | Director/Board Member | 38 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lai Yin Poon
DFI | Director of Finance/CFO | 52 | 17-08-02 |
Faat Ting Cheng
BRD | Director/Board Member | 56 | 20-08-31 |
Director/Board Member | 51 | 20-12-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 0.098 | 0.00% | 96 000 |
24-05-02 | 0.098 | 0.00% | 48,000 |
24-04-30 | 0.098 | -5.77% | 304,000 |
24-04-29 | 0.104 | +1.96% | 576,000 |
24-04-26 | 0.102 | +0.99% | 216,000 |
Delayed Quote Hong Kong S.E., May 03, 2024 at 04:09 am
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.41% | 6.27M | |
-1.89% | 12.5B | |
-9.59% | 7.67B | |
+21.44% | 5.36B | |
-1.31% | 5.26B | |
+0.02% | 4.57B | |
-51.02% | 3.15B | |
+6.42% | 2.59B | |
-10.02% | 2.06B | |
-8.29% | 1.79B |
- Stock Market
- Equities
- 8622 Stock